P499 Accessing ultrasonographic transmural healing in patients with Crohn’s disease after induction therapy with infliximab: should we aim for higher infliximab trough levels?
B Morão(Hospital Beatriz Ângelo), Carolina Palmela(Hospital Beatriz Ângelo), Maria João Ferreira, Joana Revés(Hospital Beatriz Ângelo), Maria João Moreira(Hospital da Senhora da Oliveira Guimarães), Tiago Cúrdia Gonçalves(Hospital da Senhora da Oliveira Guimarães), Rui Dinis Sousa(Centro Hospitalar de Lisboa Ocidental), José Cotter(Hospital da Senhora da Oliveira Guimarães), Marta Freitas(Hospital da Senhora da Oliveira Guimarães), Ana Teresa Caldeira(University of Macau), Francisca Dias de Castro(Hospital da Senhora da Oliveira Guimarães), C Macedo(Hospitais da Universidade de Coimbra), Guilherme Macedo(Hospital de São João), Joana Torres(University of Lisbon), L Glória(Hospital Beatriz Ângelo), C Frias Gomes(Hospital Beatriz Ângelo), Fábio Pereira(Universidade Federal de Alfenas), Rosa Coelho(Hospital de São João)
Cited by 1
Related Papers
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
|Journal of Crohn s and Colitis|2019|1.4k
ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment
|Journal of Crohn s and Colitis|2019|1.1k
KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells
|Human Molecular Genetics|2011|182